Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

RepliCel Life Sciences Inc (RP)

TSXV
Currency in CAD
0.0100
0.0000(0.00%)
Closed
RP Scorecard
Full Analysis
Net income is expected to grow this year
Trading near 52-week Low
Fair Value
Day's Range
0.01000.0150
52 wk Range
0.01000.0950
Key Statistics
Edit
Bid/Ask
0.01 / 0.015
Prev. Close
0.01
Open
0.01
Day's Range
0.01-0.015
52 wk Range
0.01-0.095
Volume
7.18K
Average Volume (3m)
56.03K
1-Year Change
-81.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

RepliCel Life Sciences Inc Company Profile

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy to treat tendon injuries, androgenetic alopecia, and skin aging by restoring cellular function to rejuvenate aging or sun damaged skin, regrow hair, and repair tendons. The company’s product candidates include RCH-01, a cell therapy for pattern baldness; RCS-01, a cell therapy foraging or sun damaged skin; and RCT-01, a cell therapy for tendon degeneration. It is also developing DermaPrecise, a dermal injection device. The company has a licensing and collaborative agreement with YOFOTO (China) Health Industry Co. Ltd. to develop and commercialize RCS-01, RCT-01, and DermaPrecise. RepliCel Life Sciences Inc. is based in Vancouver, Canada.

Compare RP to Peers and Sector

Metrics to compare
RP
Peers
Sector
Relationship
P/E Ratio
0.1x−3.3x−0.7x
PEG Ratio
0.00−0.020.00
Price/Book
0.0x0.2x2.6x
Price / LTM Sales
0.5x4.7x3.2x
Upside (Analyst Target)
-107.9%44.1%
Fair Value Upside
Unlock−2.1%8.2%Unlock

FAQ

What Is the RepliCel Life Sciences (RP) Stock Price Today?

The RepliCel Life Sciences stock price today is 0.01

What Stock Exchange Does RepliCel Life Sciences Trade On?

RepliCel Life Sciences is listed and trades on the TSXV stock exchange.

What Is the Stock Symbol for RepliCel Life Sciences?

The stock symbol for RepliCel Life Sciences is "RP."

What Is the RepliCel Life Sciences Market Cap?

As of today, RepliCel Life Sciences market cap is 650.02K.

What is RepliCel Life Sciences Earnings Per Share?

The RepliCel Life Sciences EPS is 0.019.

From a Technical Analysis Perspective, Is RP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.